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Background: This study assessed whether breast cancer (BC) patients express similar levels of needs for equivalent
severity of symptoms, functioning difﬁculties, or degrees of satisfaction with care aspects. BC patients who did (or not)
report needs in spite of similar difﬁculties were identiﬁed among their sociodemographic or clinical characteristics.
Patients and methods: Three hundred and eighty-four (73% response rate) BC patients recruited in ambulatory or
surgery hospital services completed the European Organisation for Research and Treatment of Cancer Quality of Life
questionnaire (EORTC QLQ)-C30 quality of life [health-related quality of life (HRQOL)], the EORTC IN-PATSAT32 (in-
patient) or OUT-PATSAT35 (out-patient) satisfaction with care, and the supportive care needs survey short form 34-item
(SCNS-SF34) measures.
Results: HRQOL or satisfaction with care scale scores explained 41%, 45%, 40% and 22% of variance in,
respectively, psychological, physical/daily living needs, information/health system, and care/support needs (P < 0.001).
BC patients’ education level, having children, hospital service attendance, and anxiety/depression levels signiﬁcantly
predicted differences in psychological needs relative to corresponding difﬁculties (adjusted R2 = 0.11). Medical history
and anxiety/depression levels signiﬁcantly predicted differences in information/health system needs relative to degrees
of satisfaction with doctors, nurses, or radiotherapy technicians and general satisfaction (adjusted R2 = 0.12). Unmet
needs were most prevalent in the psychological domains across hospital services.
Conclusions: Assessment of needs, HRQOL, and satisfaction with care highlights the subgroups of BC patients
requiring better supportive care targeting.
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introduction
Current clinical practice integrates instruments that provide
information about a patient’s perception of his/her health
status or care management [1]. The concept of ‘patient-
reported outcomes (PROs)’ refers to measures that are directly
obtained from the patient him or herself [2]. PROs primarily
address symptoms, functional status but also health-related
quality of life (HRQOL), and satisfaction with care, in relation
to medical drugs or devices [3].
PROs are also considered at institutional level for service
planning and monitoring [1, 4]. Among them, supportive care
needs assessment tools have been developed in the cancer ﬁeld
to directly weight the patient’s wish for supportive care
intervention [5]. Supportive care focuses on patients’ physical,
functional, and psychosocial needs, and acknowledges the
importance of the relational and communicational aspects of
care. Attending to the perception of the patient’s supportive
care needs clariﬁes where actions or resource allocation are
necessary, desirable, or useful, to help patients to overcome
their difﬁculties [6].
The subjective experience of breast cancer (BC) is of
particular concern, since it entails a traumatic diagnosis for
women at all ages and involves lengthy and complex care [7],
susceptible to hamper treatment adherence [8]. This makes it
crucial to provide appropriate supportive care for these
women. The purpose of this study was to assess the supportive
care needs of BC patients in relation to their difﬁculties as they
attend hospital services to undergo active treatment.
HRQOL, satisfaction with care, and health-care needs
(needs) cover distinct domains [5]. Fung and Hays [4] suggest
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that assessing baseline HRQOL can help identifying a problem;
then a needs’ assessment helps decide on appropriate action.
HRQOL tools shed light on the intensity of patients’
difﬁculties as a result of disease and treatment across several
domains ranging from their symptoms and physical
functioning, to cognitive and psychosocial concerns [9].
Satisfaction with care questionnaires offer insights into how the
patient perceives the quality of health-care aspects and
highlights factors underlying the link between the process of
care and its resulting outcome [10]. For example, patients’
reports about care (e.g. having received information on services
available and useful in a sensitive manner) may be related to
HRQOL and satisfaction with care.
Adapted from Fung and Hays [4] and Royse et al. [11],
Figure 1 shows a supportive care programme life cycle for BC
under active treatment in oncology hospital services. Problems
are identiﬁed through HRQOL or satisfaction with care
assessments, leading to supportive care needs assessment to
pinpoint intervention needs from the patients’ perspective, and
to the design and implementation of the intervention. Then, an
evaluation of the intervention’s effectiveness is assessed on
resulting outcomes, i.e. HRQOL and satisfaction with care. The
present study addresses the upper arrows of the picture,
exploring the relationships between HRQOL and satisfaction
with aspects of care, and reports of needs for supportive care.
Each of these concepts may be measured by instruments that
have proved their acceptability, feasibility, and sound
psychometrics on their own. In order to integrate them for
institutional care planning or monitoring as appropriate tools,
it is also important to determine their speciﬁcity and
usefulness.
In BC patients, compared with HRQOL [12], needs have
only been recently studied using quantitative measures [13];
directly assessing needs may provide information on its own.
However, HRQOL data have been shown to predict the needs
of BC patients [14–16]. Moreover, these data are often used to
infer the patient’s needs and elicit intervention [17, 18],
suggesting that an evaluation of HRQOL may sufﬁce in
indirectly identifying needs. Yet, a number of studies focusing
on the relationship between measures of HRQOL and needs
highlight important discordances between these assessments
[19] and differential clinical implications from the data they
elicit [20]. Lower needs related to symptoms or difﬁculties may
imply any of the following: the patient does not expect help
with these issues, needs have been or are being met by external
services, the patient is not burdened by these difﬁculties,
or there has been an appropriate or sufﬁcient response to
need [19].
Satisfaction with care theoretically implies fulﬁllment of
expectations [21], and these may be affected by the nature,
number, or seriousness of the patient’s health needs [22]. The
link between satisfaction with care and needs for care has
rarely been empirically tested [23]. Hospital services
dissatisfaction has been related to BC patients’ unmet health
system and information needs [14]. Lower needs relative to
similar levels of satisfaction with care may be explained by
patients’ lower expectations or wishes for speciﬁc services [24],
lack of knowledge of whether or how speciﬁc, efﬁcient care
may be accessed [25], and variations in health-care needs at
different times along the cancer trajectory [26, 27].
Hence, to help interpret the information provided by needs’
assessment in relation to HRQOL (i.e. degree of perceived
symptoms or functioning difﬁculties) or satisfaction with care
(i.e. perceptions of aspects of care quality) data, and to
highlight supportive care targets, we addressed the following
research questions:
(i) To what extent BC patients who report symptoms or
functioning difﬁculties [European Organisation for
Research and Treatment of Cancer Quality of Life
questionnaire (EORTC QLQ)-C30] or dissatisfaction with
care aspects [OUT-PATSAT35 (out-patient)/EORTC
Figure 1. Supportive care intervention programme life cycle proposal for BC under active treatment in oncology hospital services.
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IN-PATSAT32 (in patient)] express needs for supportive
care [supportive care needs survey- short form 34-item
(SCNS-SF34)]?
(ii) Which sociodemographic and clinical factors characterize
BC patients who express needs for supportive care
compared with those who do not, although they experience
similar symptoms, functioning difﬁculties, or
dissatisfaction with care aspects?
patients and methods
An ecological observational study was implemented. A consecutive series of
BC patients were recruited between April 2010 and March 2011 in the
chemotherapy (CT) day hospital and ambulatory radiotherapy (RT) service
of Institute Curie (IC) in Paris (France) and of the University Hospital
CHUV in Lausanne (Switzerland), as well as in the BC surgery unit of the
CHUV. Informed consent and local or national ethical committee approval
were obtained.
patients and data collection
Patients had to be diagnosed with BC, be aged 18 years or older, have
sufﬁcient knowledge of French, and be mentally ﬁt to complete a
questionnaire.
All questionnaires were distributed in hospital, for completion at home
within 6 weeks. Sociodemographic data (age, education level, professional
status, and having children or not) and clinical data (time since BC
diagnosis, disease stage, current ongoing anti-tumor treatment or not, and
medical history) were recorded from medical records.
questionnaires
Patients were asked to complete the French versions of the supportive care
needs survey, SCNS-SF34 [28]; the core quality of life questionnaire,
EORTC QLQ-C30 (version 3.0) [29]; the Hospital Anxiety and Depression
Scale, HADS [30]; and the cancer in-patient or out-patient satisfaction
questionnaire, EORTC IN-PATSAT32 [31] or OUT-PATSAT35 [32].
The SCNS-SF34 addresses the level of needs in the psychological,
information and health system, physical and daily living, patient care and
support, and sexuality domains. The psychometric study of the SCNS-SF34
French version conﬁrmed a ﬁve multi-item scale structure [33]. The
EORTC QLQ-C30 contains scales and items addressing the functional
aspects of HRQOL and symptoms that commonly occur in patients with
cancer. The EORTC IN-PATSAT32 assesses cancer patients’ satisfaction
with the quality of the technical and human aspects of care provided by
hospital doctors and nurses, as well as aspects of the care organization and
hospital environment. The OUT-PATSAT35 is an adapted version of the
EORTC IN-PATSAT32 assessing speciﬁc aspects of care in the hospital
ambulatory setting. Scale scores of the SNCS-SF34, EORTC QLQ-C30,
EORTC IN-PATSAT32, and OUT-PATSAT35 are calculated by averaging
items within scales and transforming average scores linearly. Scores range
from 0 to 100, so that a high score on a functioning scale, overall quality of
life, or satisfaction with care scale indicates good functioning, a good level
of overall quality of life, or a high satisfaction with care, respectively;
inversely, either a high score on a symptom scale or a need scale indicates
more severe symptoms, problems, or needs.
The HADS is a 14-item self-report scale developed for the medical
patients, assessing anxiety (HAD-A) and depression (HAD-D). Subjects
rate the frequency of anxious or depressive symptoms experienced over the
past week. The HAD-A and HAD-D scores range from 0 to 21, a higher
score indicating more distress. This questionnaire has been validated in
French in cancer in-patients [30].
statistical analyses
To answer research question 1, we carried out four multiple regression
analyses using the need scales’ scores as dependent variables. For the ﬁrst
two regressions, scores of the psychological and physical and daily living
need scales were predicted from scores of the quality of life questionnaire
subscales addressing the same domains. For the following two regressions,
scores of the information and health system and care and support need
scales were predicted from scores of the satisfaction with care subscales also
addressing the same domains.
For each regression, R² (the percentage of score explained variance)
indicates whether needs are more or less strongly predicted by either the
quality of life or satisfaction with care assessments. R² values of 1%, 9%, or
25% represent small, medium, or large effects, respectively [34].
Explanatory variables are characterized by standardized coefﬁcients,
indicating the extent to which they contribute to predict need scale scores:
standardized regression coefﬁcients of 0.1 were considered small, 0.3
medium, and 0.5 large [34]. As in each analysis, explanatory variables are
scales of a questionnaire, they are expected to be highly correlated and so
susceptible to multicollinearity and biasing results. To check
multicollinearity, for each regression, we computed the variance inﬂation
factor (VIF) estimates [35]; since the VIF was never >5, we concluded in a
small multicollinearity, which does not result too signiﬁcant bias.
To answer research question 2, we assessed differences between needs
and symptoms or functioning difﬁculties (EORTC QLQ-C30) or satisfaction
with providers’ care or general satisfaction (EORTC IN-PATSAT32/OUT-
PATSAT35). These differences were operationalized by regression residuals
(i.e.: differences between observed and predicted values by the best
combination of explanatory variables). When residuals are close to 0, need
scores are almost perfectly predicted by the EORTC QLQ-C30 or IN-
PATSAT32/OUT-PATSAT35 scores; when they are positive, observed need
scores are greater than those that could be predicted by the EORTC QLQ-
C30 or IN-PATSAT32/OUT-PATSAT35 scores; and when they are negative,
the reverse is true. These residuals are then used as dependent variables in
new regression models aimed at assessing the weight of explanatory
variables that were tested among BC patients’ sociodemographic (age,
education level, professional status, and having children) or clinical (time
since diagnosis, stages of disease, medical history, anxiety or depression, and
hospital service attended) characteristics. Statistical analyses were carried
out using the R software [36].
results
BC women characteristics and compliance
Five hundred and twenty-six BC patients were approached to
participate in this study. Of these, 127 (24%) refused to
participate and 15 (2.8%) did not provide evaluable forms.
Non-respondents were signiﬁcantly older and presented
more often with a metastatic disease, a longer time since
diagnosis, or breast reconstruction (P < 0.001) (Table 1). The
sociodemographic and clinical characteristics of the sample are
detailed in a previous study [22].
BC women self-reported data
Score means of the SCNS-SF34 ranged from 26 (care and
support needs) to 39 (psychological needs) (Table 2). On the
overall sample, unmet supportive care needs were primarily
prevalent in the psychological domain with 50% or above BC
patients reporting unmet needs regarding uncertainty about
the future, fear about the cancer spreading, information on
Annals of Oncology original articles
Volume 24 | No. 8 | August 2013 doi:10.1093/annonc/mdt128 | 
what to do to help oneself get well, or worry that the results of
treatment are beyond one’s control.
Clinical levels of anxiety or depression were observed in
20.5% and 11.3% of the samples, respectively, which reﬂects
higher levels compared with early BC patients pre-RT [37].
Score means of the EORTC QLQ-C30 functioning and global
health status scales ranged from 59 (global health status) to 75
(physical and cognitive functioning) and of symptom scales
from 11 (nausea and diarrhoea) to 50 (fatigue), which reveals
more difﬁculties or symptoms than reference data for all stages
BC patients aged between 50 and 60 years [38]. Score means of
the EORTC IN-PATSAT32 or OUT-PATSAT35 ranged from
61 (doctors’ availability) to 78 (nurses’ interpersonal skills)
evidencing higher satisfaction with doctors’ information than
all cancer patients data [39].
predicting psychological, physical, and daily living
needs by BC patients’ reported corresponding
difﬁculties
Moderate proportions of variance in the SCNS-SF34
psychological, physical and daily living need scores were
explained by EORTC QLQ-C30 corresponding scales (adjusted
R2 = 0.41 and 0.45, respectively; P < 0.001). Lower emotional
functioning only was signiﬁcantly associated with
psychological needs (β =−0.55). Physical functioning
(β =−0.14), fatigue (β = 0.17), pain (β = 0.19), dyspnoea
(β = 0.13), and constipation (β = 0.09) were signiﬁcantly
associated with physical and daily living needs but not role
functioning, global health status, nausea, appetite loss, and
diarrhoea (supplementary Table S1, available at Annals of
Oncology online).
predicting needs for information and health
system, care and support by BC patients’
satisfaction with care aspects
The proportions of variance explained in the SCNS-SF34
information and health system, care and support need scales
by the EORTC IN-PATSAT32 or OUT-PATSAT35 doctors/
nurses/RT technicians, and general satisfaction scales were
moderate (adjusted R2 = 0.40; P < 0.001) and small (adjusted
R2 = 0.22; P < 0.001). Higher satisfaction with doctors’
interpersonal skills (β =−0.19) and information provision
(β =−0.37), and higher general satisfaction (β =−0.15) were
associated with lower information or health system needs.
Higher satisfaction with doctors’ information provision
((β = −0.19) and higher general satisfaction (β =−0.18) were
associated with lower care and support needs (supplementary
Table S2, available at Annals of Oncology online).
Table 1. Sample sociodemographic and clinical characteristics
Respondents
(N = 384)
n (%)
Non-respondents
(N = 142)
n (%)
Age (years)*
Mean (SD) 54.0 (11.3) 57.7 (12.7)
Married/with a partner 237 (61.7) 89 (65.9)
Missing data 0 7
Education
Up to superior 197 (51.7) –
Superior or above 184 (48.3) –
Missing data 3 –
Having children 295 (76.8) 106 (74.6)
Length of time since diagnosis and questionnaire completion (months)
Median [range] 6.3 [0.5–284.4] –
Missing data 1 –
Stage of breast cancer*
Local/regional 310 (80.7) 89 (63.1)
Metastatic 74 (19.3) 52 (36.9)
Missing data 0 1
Hospital service*
France
Chemotherapy day hospital 145 (37.8) 104 (73.2)
Ambulatory radiotherapy 103 (26.8) 23 (16.2)
Switzerland
Chemotherapy day hospital 34 (8.9) 3 (2.1)
Ambulatory radiotherapy 55 (14.3) 7 (4.9)
Surgery 47 (12.2) 5 (3.5)
Mastectomy 121 (31.5) 48 (34.0)
Missing data 0 1
Breast reconstruction (yes)
(patients with surgery only)
(n = 456)*
22 (6.7) 19 (15.0)
Missing data 1 2
Signiﬁcant difference between respondents and non-respondents: *P < 0.01
(two-tailed).
Table 2. Self-reported anxiety and depression and supportive care needs
mean (standard deviation) scale scores and prevalence of top 10 unmet
supportive care needs (N = 384)
HADS
Mean (SD)—% clinical case (score >10)
Anxiety 7.3 (3.8)—20.5
Depression 5.3 (4.0)—11.3
Supportive care needs mean (SD)
Psychological needs 38.5 (24.2)
Information and health system 33.4 (19.2)
Care and support 26.2 (17.4)
Physical and daily life needs 34.5 (23.3)
Sexual needs 30.2 (32.4)
Top 10 unmet supportive care % unmet needs
Uncertainty about the futurea 64.1
Fears about the cancer spreadinga 58.9
Being informed about things you can
do to help yourself to get wellb
58.3
Worry that the results of the treatment are
beyond your controla
56.9
Not being able to do things you used to doc 53.8
Learning to feel in control of your situationa 53.3
Lack of energy/tirednessc 50.1
Anxietya 49.3
Concerns about the worries of those close to youa 48.1
Feelings about death and dyinga 45.7
aPsychological needs.
bHealth system and information needs.
cPhysical and daily living needs.
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BC patients’ characteristics explaining higher or
lower psychological, physical, and daily living
needs for similar level reported difﬁculties
As reported in Table 3, in multivariate analysis, discrepancies
between SCNS-SF34 psychological needs and the EORTC
QLQ-C30 corresponding scales were signiﬁcantly predicted
(adjusted R2 = 0.11; P < 0.001) by BC patients’ education level
(β =−0.20), having children (β = 0.13), hospital service
(β =−0.13; β =−0.16), and anxiety (β = 0.15) or depression
(β = 0.13) levels. BC patients with a superior level of education
or attending speciﬁc hospital services presented lower levels of
psychological needs than expected from their EORTC QLQ-
C30 level of emotional, cognitive, social functioning, global
health status, fatigue, or sleep difﬁculties compared with
women with a compulsory level of education, whereas BC
patients having children or with a higher anxiety or depression
level evidenced higher psychological needs than expected from
their reported difﬁculties. However, the multivariate model did
not signiﬁcantly predict discrepancies between SCNS-SF34
physical and daily living needs and the EORTC QLQ-C30
corresponding scales (adjusted R2 = 0.02).
BC women characteristics explaining higher/lower
needs for information and health system, and care
and support for similar level satisfaction with
doctors, nurses, or radiotherapy technicians’ care
and general satisfaction
As reported in Table 4, in multivariate analyses, discrepancies
between the SCNS-SF34 information and health system need
scale scores and scores of the EORTC IN-PATSAT32 or
OUT-PATSAT35 doctors/nurses/RT technicians and general
satisfaction scales were signiﬁcantly predicted (adjusted
R2 = 0.11; P < 0.001) by BC medical history (β =−0.11), anxiety
(β = 0.15), and depression (β = 0.20). BC patients who
Table 3. BC women characteristics explaining higher/lower psychological
or physical and daily living needs for similar levels of reported difﬁculties
Factors Psychological needs and
corresponding EORTC
QLQ-C30 scale differences
Physical and daily living
needs and EORTC QLQ-
C30 corresponding scale
differences
β β
Age NS NS
Education level (reference = compulsory)
Secondary NS NS
Technical–
professional
NS NS
Superior −0.20* NS
Professional status (working)
Having
children
0.13* NS
Hospital services (reference = CT-IC)
RT-IC NS −0.16*
CT-CHUV −0.13* NS
Surgery-
CHUV
−0.16* NS
RT-CHUV NS NS
Time since
diagnosis
NS NS
Metastatic
disease
NS NS
On-treatment NS NS
Medical
history
NS NS
HADS-anxiety 0.15* NS
HADS-
depression
0.13* NS
Adjusted R² 0.11 0.02
F statistics 3.91*** 1.52
df 15,345 15,344
Signiﬁcant predictors: *P < 0.05; ***P < 0.001.
NS, non-signiﬁcant; CT, chemotherapy; RT, radiotherapy; IC, Institute
Curie; CHUV, University Hospital Center Vaudois.
Table 4. BC women characteristics explaining higher/lower needs for
information and health system, and care and support for similar levels of
satisfaction with doctors, nurses, or radiotherapy technicians’ care and
general satisfaction
Factors Information and health
system needs and
corresponding satisfaction
with care scale differences
Care and support needs
and corresponding
satisfaction with care scale
differences
β β
Age NS NS
Education level (reference = compulsory)
Secondary NS NS
Technical–
professional
NS NS
Superior NS NS
Professional
status
(working)
NS NS
Having children NS NS
Hospital services (reference = CT-IC)
RT-IC NS NS
CT-CHUV NS 0.13*
Surgery-
CHUV
NS NS
RT-CHUV NS NS
Time since
diagnosis
NS NS
Metastatic
disease
NS NS
On-treatment NS NS
Medical history −0.11* NS
HADS-anxiety 0.15* NS
HADS-
depression
0.20** NS
Adjusted R² 0.12 0.00
F statistics 3.97*** <1
df 16,337 16, 329
Only signiﬁcant predictors reported: *P < 00.05; **P < 0.01; ***P < 0.001.
NS, non-signiﬁcant; CT, chemotherapy; RT, radiotherapy; IC, Institute
Curie; CHUV, University Hospital Center Vaudois.
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experienced a medical history displayed lower information and
health system needs for similar levels of satisfaction with
doctors, nurses, or RT technicians and general satisfaction,
whereas those who presented higher levels of anxiety or
depression manifested higher needs on that scale relatively to
their level of satisfaction with care. The multivariate model did
not signiﬁcantly predict discrepancies between the SCNS-SF34
care and support need scale scores and scores of the EORTC
IN-PATSAT32 or OUT-PATSAT35 doctors/nurses/RT
technicians and general satisfaction scales (adjusted R2 = 0.00).
discussion
In this study, BC patient subgroups expressed supportive care
needs, but others did not although experiencing similar levels
of symptoms, functioning difﬁculties, or (dis)satisfaction with
care aspects. Indeed, moderate score variation in supportive
care needs as measured by the SCNS-SF34 was explained by
those EORTC QLQ-C30 scales addressing similar items or
domains, and moderate and small score variances in needs for
information and health system, or care and support were
explained by satisfaction with the care provided by doctors,
nurses, or RT technicians and by general satisfaction.
Factors related to BC patients and hospital services explained
differences in expressing needs. For example, higher levels of
psychological needs for similar levels of emotional difﬁculties
were observed in BC patients with children or those presenting
clinical levels of anxiety or depression, which suggests
insufﬁcient attention to the needs of these patients. The higher
needs of BC patients with clinical levels of distress relative to
difﬁculties revealed by the EORTC QLQ-C30 on psychological
domains indicate that the EORTC QLQ-C30 may not be
sufﬁciently sensitive for use as a distress-screening instrument.
BC women with a superior level of education expressed
lower needs for psychological help for similar levels of
difﬁculty, which suggests higher self-efﬁcacy in obtaining
external services, if necessary, compared with women with a
lower level of education. Needs were lower in speciﬁc oncology
services compared with others for similar levels of symptoms
and difﬁculties implying differences between services in terms
of responsiveness to patients’ psychological needs.
On average, higher needs were observed in the psychological
domain in this BC patients’ sample, at that time of their
disease trajectory and treatment location. This contrasts with
the other studies using the SCNS-SF34 questionnaire on
similar BC samples but in Asian countries where higher needs
were evidenced in the health system and information domain
[14, 16, 40, 41]. BC patients’ reports of such unmet needs
highlight requirement for additional active listening (e.g. to
understand barriers to service access), patient education about
the disease and treatment process, or referral to social services
(e.g. child care assistance) or psychological counselling [42, 43]
in order to help them learn efﬁcient strategies for uncertainty
or anxiety management [44].
Only satisfaction with doctors’ information provision
weighted on the health system and information need scale;
hence, BC patients may look essentially to doctors for
information provision. BC patients who had previous medical
experience expressed lower needs for information and health
system for similar levels of satisfaction with care compared
with those with no such experience. Perhaps those BC patients
with medical antecedents, more acquainted to the health-care
system than novice patients, expected less response to their
information needs.
At similar levels of satisfaction with care, BC patients with
high psychological distress expressed higher needs for
information underlining the importance of fulﬁlling BC
women health information needs for their psychological well-
being. This observation also suggests that discrepancies
between speciﬁc BC patients’ reported needs related to their
satisfaction with care may reﬂect deﬁciencies in the care
provided, which may be addressed for enhanced care
targeting.
Different other factors should be explored to explain why BC
patients do or do not express needs despite similar levels of
difﬁculties. These include patient-related factors, social support
[45], psychological (e.g. personality [46]), or among clinicians-
related factors, gender, personality, length of relationship with
patient [47], and attitude to patient’s health status [48].
Among hospital-related factors, research is under-developed
with regard to the role of care structure (e.g.: volume, staff-to-
patient ratio, equipment, teaching/research activity,
communication training available, multidisciplinary team… )
or process (e.g.: guidelines, clinical case management (RCP),
referral/coordination… ) on response to needs in oncology
[39, 49].
This study presents several limitations considering its cross-
sectional design and speciﬁc ecological context. Supportive
care need scales were tested as dependent variables, whereas
these could have explained quality of life or satisfaction with
care. Although recruited in two French-speaking nations of
different health-care systems and city size, this sample may
only reﬂect upon the BC population of these two institutions;
supportive care needs have been shown to differ across
cultures [15]. The consecutive recruitment approach reﬂects
the clinical practice of the hospital services in which the
study took place and the resulting sample does not allow
generalization across disease stages. Moreover, respondents
were younger and confronted with less advanced disease
compared with non-respondents.
However, supportive care needs in relation to HRQOL and
satisfaction assessments provided complementary information,
which enabled to identify subgroups of BC patients who
required better care in hospital services for BC treatment.
Although experiencing similar degrees of symptoms, functional
difﬁculties, or (dis)satisfaction with care aspects, particular BC
patients expressed higher needs pointing to targets for care
improvement. Across hospital services, BC patients’ needs were
mostly prevalent in the psychological domain; however, BC
patients with children, with a lower level of education, or with
psychological distress would require additional attention to
ensure that any BC patients beneﬁt from optimal care and
treatment.
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Melanoma patients in a phase I clinic: molecular
aberrations, targeted therapy and outcomes
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Background: The purpose of the study was to assess the outcome of patients with advanced melanoma treated with
matched molecularly targeted therapy.
Patients and methods: We reviewed 160 consecutive patients with metastatic melanoma treated in the phase I
program (N = 35 protocols). Treatment was considered to be ‘matched’ (N = 84) if at least one drug in the regimen was
known to inhibit the functional activity of at least one of the patient’s mutations.
Results: Of 160 patients, 134 (83.7%) had adequate tissue for molecular analysis; 69% (110 of 160) had ≥1 mutation:
61.2% (82 of 134), BRAF; 20.7% (23 of 111), NRAS; 2.6% (2 of 77), KIT; 2.3% (1 of 44), KRAS; 20% (1 of 5), GNAQ;
11.1% (1 of 9), P53 and 2.6% (1 of 39), coexisting mutations in BRAF and PIK3CA. Eighty-four patients (52.4%) were
treated with matched-targeted agents, most of whom had BRAF mutations (N = 74). Twenty-six percent of patients
(41 of 160) achieved a complete or partial remission (CR/PR) [40% (34 of 84)) on a matched phase I protocol versus
9.2% (7 of 76) for those on a non-matched study (P≤ 0.0001)]. The median progression-free survival (PFS) (95% CI)
was longer for patients treated on a matched phase I trial than on their prior ﬁrst standard treatment [5.27 (4.10, 6.44)
versus 3.10 (1.92, 4.28) months, P = 0.023], but not on non-matched phase I treatment. Multivariable analysis showed
that matched therapy was an independent predictor of higher CR/PR rates, prolonged PFS and survival.
Conclusions: For melanoma patients, especially those with BRAF mutations, administering molecularly matched
agents can be associated with better outcomes, including longer PFS compared with their ﬁrst-line systemic therapy.
Key words: melanoma, targeted therapy, metastatic melanoma, matched therapy, phase I
introduction
Patients with advanced melanoma are treated with palliative
surgery, immunotherapy and/or chemotherapy and sometimes
radiation therapy [1–4]. Metastatic melanoma is rarely curable
with standard therapeutic modalities. Current chemotherapy
and cytokine-based immunotherapy [1–4] approaches beneﬁt
only a small percentage of patients with advanced disease.
High-dose interleukin-2 (IL-2) [5, 6] has been reported to
produce durable responses in only a small number of patients
(<10%). Single-agent dacarbazine [7] has historically been the
chemotherapy of choice for patients with advanced melanoma,
with a response rate of 7%–15% and no overall survival (OS)
beneﬁt [7]. Other standard therapies according to National
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